IQVIA Strengthens Early-Stage Discovery Research with Advanced In Vitro and AI-Driven Solutions Why is the life sciences industry facing a critical need for accelerated drug discovery? IQVIA Holdings Inc. a global leader in advanced analytics, technology solutions, and clinical research…
Strategic Move to Attract and Retain Talent in the Biotech Sector What does it take to attract top talent in the highly competitive biotech industry? Sensei Biotherapeutics, Inc. a clinical-stage biotechnology company focused on developing next-generation therapeutics for cancer patients,…
Regulatory Milestone Enables European Expansion of Advanced Proton Therapy Why is proton therapy still out of reach for many European cancer centers? Mevion Medical Systems, the global leader in compact proton therapy, has announced that the MEVION S250-FIT Proton Therapy…
Leadership Transition Signals Ascensia’s Commitment to Long-Term Growth and Innovation Why is the leadership transition at Ascensia Diabetes Care significant for the global healthcare industry? Ascensia Diabetes Care, a global leader in diabetes management solutions, has announced the appointment of…
Ionis Poised for Continued Growth with Multiple Upcoming Therapeutic Launches Is the biotech industry ready for a new wave of transformative therapies? Ionis Pharmaceuticals, a leader in RNA-targeted therapies, reported robust financial results and significant pipeline advancements for the year ended…
Kivu Bioscience Secures HREC Approval and CTN Clearance for Next-Generation ADC Why are next-generation antibody-drug conjugates (ADCs) crucial for advancing cancer treatments? Kivu Bioscience, a clinical-stage biotechnology company based in San Mateo, CA, is making significant strides in this area.…
Epredia and Mindpeak Announce Distribution Agreement for AI-Based Image Recognition Software As cancer cases rise and diagnostic processes become more complex, pathology laboratories face increasing pressure to speed up processes and reduce costs. Epredia, a global leader in precision cancer…
Verdiva Bio Advances Obesity Therapy with Once-Weekly Oral GLP-1 Peptide Analog Is the pharmaceutical industry on the brink of a breakthrough in obesity treatment? Verdiva Bio Limited a clinical-stage biopharmaceutical company focused on developing innovative therapies for obesity and cardiometabolic…
Streamlining Compliance and Improving Client Care in Los Angeles County In an era where mental health services are increasingly data-driven, how can organizations ensure they meet regulatory requirements without sacrificing client care? Greenspace Health has the answer. The company, which…
Preclinical Study Shows Targeted Degradation of MYC and KRAS Using Bionic Biologics Platform Why have traditional cancer treatments struggled to target the most aggressive forms of the disease? Grove Biopharma, a private biotechnology company based in Chicago, is addressing this…
DECA Dental Group Adopts Pearl’s AI to Improve Clinical Outcomes and Patient Engagement In the rapidly evolving landscape of dental technology, the integration of artificial intelligence (AI) is becoming a game-changer. Pearl, the global leader in dental AI solutions, has…
Rebranding and New Platform Reflect Alluvium’s Commitment to Unified Data Management How can health systems navigate the complex challenges of capacity management and revenue optimization? Alluvium, formerly known as BlockIt, is addressing this critical issue with the launch of its…